Overall, this data shows gartisertib to be a potent ATR inhibitor, especially in MGMT promoter unmethylated glioblastoma cell lines, in which DDR gene mutations and higher expression of cell cycle genes/pathways associated with greater sensitivity to ATR inhibition. Here, MGMT is linked to glioblastoma.